|
rdfs:label
|
"Everolimus"@de
"Everolimus"@es
"Everolimus"@it
"Everolimus"@nb
"Everolimus"@nl
"Everolimus"@sh
"Everolimus"@tr
"Everolimus"@vi
"Everolimus"@id
"Everolimus"@sk
"everolimo"@pt
"everolimus"@en
"everolimus"@nn
"everolimus"@sl
"everolimusz"@hu
"everolimuusi"@fi
"everolimús"@ca
"ewerolimus"@pl
"évérolimus"@fr
"еверолимус"@sr
"еверолімус"@uk
"эверолимус"@ru
"эвэралімус"@be-tarask
"إيفيروليموس"@ar
"اورولیمس"@azb
"اورولیمس"@fa
"ଏଭେରୋଲିମସ"@or
"エベロリムス"@ja
"依維莫司"@zh
"依维莫司"@zh-cn
"依维莫司"@zh-hans
|
|
skos:altLabel
|
"40-O-(2-hydroxyethyl)-rapamycin"@en
"42-O-(2-hydroxyethyl)rapamycin"@en
"Afinitor"@nb
"Afinitor"@pt
"RAD-001"@de
"RAD-001"@pl
"RAD001"@en
"SDZ-RAD"@en
"everolimus"@it
"アフィニトール"@ja
"サーティカン"@ja
"依维莫司"@zh
"癌伏妥"@zh
|
|
schema:description
|
"Arzneistoff"@de
"Kompozé chimik"@gcr
"agent antinéoplasique et médicament immunosuppresseur"@fr
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"composito chimic"@ia
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"conposto chìmego"@vec
"cumpostu chìmicu"@scn
"cyfansoddyn cemegol"@cy
"gemyske ferbining"@fy
"kediad kimiek"@br
"keemiline ühend"@et
"kemia kombinaĵo"@eo
"kemiala kompozajo"@io
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"senyawa kimia"@id
"związek chemiczny i lek"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"хемиско соединение"@mk
"химическое соединение"@ru
"химично съединение"@bg
"хімічна сполука"@uk
"хімічнае злучэнне"@be
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଏହା କ ଔଷଧ ଯାହା କେତେକ ପ୍ରକାରର କର୍କଟ ରୋଗର ଚିକିତ୍ସା ପାଇଁ କରାଯାଉଥିବା ଅଙ୍ଗ ପ୍ରତିରୋପଣ ପରେ ପ୍ରତ୍ୟାଖ୍ୟାନକୁ ରୋକିବା ପାଇଁ ବ୍ୟବହାର କରାଯାଏ ।"@or
"രാസസംയുക്തം"@ml
"免疫抑制剤・抗がん剤の一つ"@ja
"化合物"@yue
"化合物"@zh
"化合物"@zh-cn
"化合物"@zh-hans
"化合物"@zh-hant
"化合物"@zh-hk
"化合物"@zh-sg
"化合物"@zh-tw
"化合物"@zh-mo
|
|
schema:dateModified
|
"2026-01-19T14:57:15+00:00"^^xsd:dateTime
|
|
schema:version
|
2456122657
|
|
wikibase:identifiers
|
38
|
|
wikibase:sitelinks
|
27
|
|
wikibase:statements
|
82
|
|
p:P10245
|
wd:statement/Q421052-92a76087-4551-b0cb-ba50-cdb96aec06cb
|
|
p:P10283
|
wd:statement/Q421052-E531D446-DCA7-41D6-AFF3-0486CF3EAC5A
|
|
p:P11089
|
wd:statement/Q421052-EDCF14BF-DA5A-4DD9-BB3A-F589506DCBF0
|
|
p:P11143
|
wd:statement/Q421052-2423EDFB-9023-4356-A13D-A4A49B4E2320
|
|
p:P11198
|
wd:statement/Q421052-CBB3F08F-04B3-44F7-8FD9-133D30012634
|
|
p:P11199
|
wd:statement/Q421052-DFCCD16E-6747-4202-9B30-977FB20AB3B5
|
|
p:P117
|
wd:statement/Q421052-8DDC2431-D591-4BA3-BA0C-5575C09CD53D
|
|
p:P129
|
wd:statement/Q421052-A61A2100-4A6C-44C0-84D9-B7E5F4DB2BEB
|
|
p:P2017
|
wd:statement/Q421052-696F8CE2-B8C3-4BA0-8C29-861B3C2B71FD
|
|
p:P2057
|
wd:statement/Q421052-E4E631EC-3F64-4D58-9D44-54A8BAA8C995
|
|
p:P2062
|
wd:statement/Q421052-33978093-69F1-44FF-BB23-4B6242F4141A
|
|
p:P2067
|
wd:statement/Q421052-40B65F8B-38F1-4643-B145-587D071A6F02
|
|
p:P2115
|
wd:statement/Q421052-CFC330B6-D01E-4B02-8D2D-D2811E73B9EE
|
|
p:P2175
|
wd:statement/Q421052-198E6838-3001-4E55-80C1-85D13A2627CA
|
|
wd:statement/Q421052-1B87268F-42A9-49F5-946A-80A402323C56
|
|
wd:statement/Q421052-1C9AAC38-5204-4F22-8437-C12A93E5EF6D
|
|
wd:statement/Q421052-237944D0-E8AD-463E-B862-214C4DB8495B
|
|
wd:statement/Q421052-3DF58F3E-FF8E-4F4D-A8FF-4068BBCE82A9
|
|
wd:statement/Q421052-51E4943C-85D5-4FB2-8C0D-566B1BDCD392
|
|
wd:statement/Q421052-67B2DAE3-D592-48E1-A199-840C00C58DAB
|
|
wd:statement/Q421052-6A79B747-1BE2-43BF-B433-822E9450058A
|
|
wd:statement/Q421052-6B9CEE5D-CDC6-4E73-B4C5-8F16C8BB76EB
|
|
wd:statement/Q421052-795A8D1E-56DA-4290-AE97-89FF6C621C11
|
|
wd:statement/Q421052-806F7D83-4F89-4825-9632-F8CBFCD62718
|
|
wd:statement/Q421052-873a0707-4285-9f51-4c06-bc126be6d5b2
|
|
wd:statement/Q421052-8B349EA3-3E44-4F33-A9F5-306B484247B4
|
|
wd:statement/Q421052-92BFEEE8-BBE5-4C0B-97C7-4BDBDD0EE49A
|
|
wd:statement/Q421052-C3F1EFFC-010B-4F51-9744-EA1BEA4E45AF
|
|
wd:statement/Q421052-C4B54408-79FF-41F1-8F06-166F1ADA6C02
|
|
wd:statement/Q421052-C9281C35-6AD0-41DF-B965-F2DDA5FEAB4E
|
|
wd:statement/Q421052-E72BADF1-2E18-44B5-8D82-93A992416CAD
|
|
wd:statement/Q421052-ED2AD95D-0CBB-4537-A2A6-C116DD362894
|
|
p:P2275
|
wd:statement/Q421052-3DD73884-14E4-419E-A045-0D62A3833ED2
|
|
p:P231
|
wd:statement/Q421052-93FA5B4B-2EBC-422C-B96E-90ED3AB33199
|
|
p:P232
|
wd:statement/Q421052-43601B32-F5F8-4F5D-904D-286F4A1B75E9
|
|
p:P233
|
wd:statement/Q421052-4183C736-A6E7-4B10-BF38-B3D1FBF403EB
|
|
p:P234
|
wd:statement/Q421052-3A681B39-5C2A-4754-845D-9C808F0C0439
|
|
p:P235
|
wd:statement/Q421052-15644FED-243F-4EAF-9BA4-B013B4569995
|
|
p:P2566
|
wd:statement/Q421052-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q421052-0A44FAC3-38D5-4702-8A4B-43B349D6EE54
|
|
wd:statement/Q421052-7BE29BEC-1D93-400B-8131-7F03B06CAD03
|
|
p:P274
|
wd:statement/Q421052-3E00A127-F3EF-4C10-8E34-117672F12C07
|
|
p:P279
|
wd:statement/Q421052-869704C9-0347-42C9-BC9A-50DD3DE0C716
|
|
p:P2868
|
wd:statement/Q421052-079F6B63-134F-45E8-B2AB-E6D0278BB81C
|
|
wd:statement/Q421052-6BE0F98E-1036-445E-BE51-E3990EB840D0
|
|
wd:statement/Q421052-DE885C8A-ECF1-4698-97AF-7ECFEDF2DB83
|
|
wd:statement/Q421052-F315F9B2-CF31-4FBD-B2AD-A6DCD2452901
|
|
p:P2877
|
wd:statement/Q421052-0CDCDAB6-948B-4B04-8523-BF888306B7AD
|
|
p:P2892
|
wd:statement/Q421052-50B03938-7CCD-4527-9B23-4639777B056A
|
|
p:P31
|
wd:statement/Q421052-381D4B9D-74E2-47EB-AEEF-6A6E5EE2C619
|
|
p:P3117
|
wd:statement/Q421052-7C331E23-BAD3-4247-B8F5-CACC5AF7D4DF
|
|
p:P3345
|
wd:statement/Q421052-1C5FAB54-C5DD-4C23-8E86-8F6793C78FBD
|
|
p:P3350
|
wd:statement/Q421052-1fadc933-4808-c303-8805-d6f44abb6454
|
|
p:P3364
|
wd:statement/Q421052-4AED7657-0BAA-4117-B1DC-2CD86FCCD236
|
|
p:P3489
|
wd:statement/Q421052-1EDDBE40-3F37-4BA7-B537-F518D569FA11
|
|
p:P3493
|
wd:statement/Q421052-FB55594C-7E72-481E-B55B-6C7029E16A09
|
|
p:P366
|
wd:statement/Q421052-AC97A7AC-14CA-45EC-B273-89FD0AE4E7A6
|
|
p:P373
|
wd:statement/Q421052-a43e5985-4f2a-d28f-8d66-824482d5fa28
|
|
p:P3780
|
wd:statement/Q421052-126A8E20-2CA0-4452-B69B-3478BE1C3932
|
|
wd:statement/Q421052-C1EF5549-512C-4C80-8903-4BD19DF29A72
|
|
wd:statement/Q421052-c83a5f72-4585-fb21-ceae-6c758f774a23
|
|
p:P4235
|
wd:statement/Q421052-E138490B-6048-49D6-AA5F-00B210F9DFF5
|
|
p:P4250
|
wd:statement/Q421052-1C2E5BE2-300B-403A-9227-84C0F6294C81
|
|
p:P4527
|
wd:statement/Q421052-01305D07-40E7-4E89-9001-1A907EB2A08A
|
|
p:P486
|
wd:statement/Q421052-F1D47497-F61A-4960-9197-A5D741804021
|
|
p:P527
|
wd:statement/Q421052-A81907EA-CF60-41E7-B3E5-E996BD5EFBF0
|
|
p:P592
|
wd:statement/Q421052-0B91130D-F673-4D81-8C27-FFA4C39D2DEB
|
|
p:P595
|
wd:statement/Q421052-B1DA4976-BCAE-4302-95FB-1C52C1B7BDF0
|
|
p:P6366
|
wd:statement/Q421052-949D252A-374D-4EDE-9F3B-B5CECB9C87C1
|
|
p:P646
|
wd:statement/Q421052-46F8CE15-A590-4DC6-ADE3-278EE3B58AF1
|
|
p:P652
|
wd:statement/Q421052-AD8DC712-FEB1-40A7-9DD7-5727CEB573F9
|
|
p:P661
|
wd:statement/Q421052-39A7C8EF-E206-4DEC-88C5-119DE6C6CE01
|
|
p:P662
|
wd:statement/Q421052-5BB95CCD-CC8D-492D-B634-81A6DEC7498A
|
|
p:P665
|
wd:statement/Q421052-7A2A0CF6-D175-43C9-8543-B2E1ECB25D7E
|
|
p:P672
|
wd:statement/Q421052-a18aa500-4c6f-e493-6047-8c27e4f4962a
|
|
p:P683
|
wd:statement/Q421052-725E1B2C-7518-4205-8780-CC4EEA2DAF74
|
|
p:P715
|
wd:statement/Q421052-52F737D4-501D-41E1-80D0-42616EF8BA3E
|
|
p:P769
|
wd:statement/Q421052-E12DE2D7-4763-42B9-BF89-882C2589D129
|
|
p:P7830
|
wd:statement/Q421052-A6256715-F21A-4B50-8FE2-5BF7C2B1944E
|
|
p:P8026
|
wd:statement/Q421052-8850EBA2-C875-42CF-BA1B-6134A9700606
|
|
p:P8494
|
wd:statement/Q421052-861D8494-3344-4C37-9D46-58029905D815
|
|
p:P9272
|
wd:statement/Q421052-2452FFF5-532F-4132-AE00-2CCB9E7C8C6D
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000178379>
|
|
p:direct-normalized/P4527
|
<http://data.parliament.uk/terms/418338>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D000068338>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1908360>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2779699572>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/21106307>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D02714>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D02.540.505.760.500>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_68478>
|
|
wdt:P10245
|
"a609032"
|
|
wdt:P10283
|
"C2779699572"
|
|
wdt:P11089
|
"1077088"
|
|
wdt:P11143
|
"Everolimus"
|
|
wdt:P11198
|
"1118"
|
|
wdt:P11199
|
"PD004083"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Everolimus.svg>
|
|
wdt:P129
|
mechanistic target of rapamycin kinase
|
|
wdt:P2017
|
"C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC"
|
|
wdt:P2057
|
"HMDB0015529"
|
|
wdt:P2062
|
"8255"
|
|
wdt:P2067
|
957.581^^xsd:decimal
|
|
wdt:P2115
|
"N0000178379"
|
|
wdt:P2175
|
renal cell carcinoma
|
|
breast cancer
|
|
carcinoid tumor
|
|
neuroendocrine carcinoma
|
|
renal clear cell carcinoma
|
|
small intestine carcinoma
|
|
kidney angiomyolipoma
|
|
neuroendocrine tumor
|
|
lymphoma
|
|
diffuse large B-cell lymphoma
|
|
acute myeloid leukemia
|
|
kidney cancer
|
|
carcinoid syndrome
|
|
angiomyolipoma
|
|
low-grade astrocytoma
|
|
benign neoplasm of brain
|
|
tuberous sclerosis 1
|
|
islet cell carcinoma
|
|
wdt:P2275
|
"everolimus"@en
|
|
wdt:P231
|
"159351-69-6"
|
|
wdt:P232
|
"621-003-9"
|
|
wdt:P233
|
"CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC"
|
|
wdt:P234
|
"InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1"
|
|
wdt:P235
|
"HKVAMNSJSFKALM-GKUWKFKPSA-N"
|
|
wdt:P2566
|
"100.149.896"
|
|
wdt:P267
|
"L01XE10"
|
|
"L04AA18"
|
|
wdt:P274
|
"C₅₃H₈₃NO₁₄"
|
|
wdt:P279
|
LSM-4258
|
|
wdt:P2868
|
immunosuppressive drug
|
|
antineoplastic
|
|
xenobiotic-transporting ATPase inhibitor
|
|
protein kinase inhibitors
|
|
wdt:P2877
|
"4378"
|
|
wdt:P2892
|
"C0541315"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID0040599"
|
|
wdt:P3345
|
"141704"
|
|
wdt:P3350
|
"7863"
|
|
wdt:P3364
|
LSM-5313
|
|
wdt:P3489
|
US pregnancy category D
|
|
wdt:P3493
|
boxed warning
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Everolimus"
|
|
wdt:P3780
|
Afinitor
|
|
Votubia
|
|
Zortress
|
|
wdt:P4235
|
"everolimus"
|
|
wdt:P4250
|
1.5^^xsd:decimal
|
|
wdt:P4527
|
"418338"
|
|
wdt:P486
|
"D000068338"
|
|
wdt:P527
|
carbon
|
|
wdt:P592
|
"CHEMBL1908360"
|
|
wdt:P595
|
"5889"
|
|
wdt:P6366
|
"2779699572"
|
|
wdt:P646
|
"/m/02m34c"
|
|
wdt:P652
|
"9HW64Q8G6G"
|
|
wdt:P661
|
"21106307"
|
|
wdt:P662
|
"6442177"
|
|
wdt:P665
|
"D02714"
|
|
wdt:P672
|
"D02.540.505.760.500"
|
|
wdt:P683
|
"68478"
|
|
wdt:P715
|
"DB01590"
|
|
wdt:P769
|
idelalisib
|
|
wdt:P7830
|
"Everolimus"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category E*
|
|
wdt:P8494
|
"DTXCID8020599"
|
|
wdt:P9272
|
"55896"
|